BROWN JAMES F 4
4 · BELLICUM PHARMACEUTICALS, INC · Filed Jan 6, 2022
Insider Transaction Report
Form 4
BROWN JAMES F
Director
Transactions
- Exercise/Conversion
Common Stock
2022-01-04+28,384→ 28,384 total - Exercise/Conversion
Restricted Stock Units
2022-01-04−28,384→ 0 total→ Common Stock (28,384 underlying)
Footnotes (2)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock.
- [F2]The RSUs vest in full upon the one year anniversary of grant date on January 4, 2021.